454 related articles for article (PubMed ID: 7991613)
1. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo A; Yankner BA
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12243-7. PubMed ID: 7991613
[TBL] [Abstract][Full Text] [Related]
2. Amyloid fibril toxicity in Alzheimer's disease and diabetes.
Lorenzo A; Yankner BA
Ann N Y Acad Sci; 1996 Jan; 777():89-95. PubMed ID: 8624132
[TBL] [Abstract][Full Text] [Related]
3. Congo red protects against toxicity of beta-amyloid peptides on rat hippocampal neurones.
Burgevin MC; Passat M; Daniel N; Capet M; Doble A
Neuroreport; 1994 Dec; 5(18):2429-32. PubMed ID: 7696573
[TBL] [Abstract][Full Text] [Related]
4. Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-beta neurotoxicity.
May PC; Boggs LN; Fuson KS
J Neurochem; 1993 Dec; 61(6):2330-3. PubMed ID: 8245987
[TBL] [Abstract][Full Text] [Related]
5. Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide.
Milton NG; Harris JR
Micron; 2013 Jan; 44():246-53. PubMed ID: 22854213
[TBL] [Abstract][Full Text] [Related]
6. Laminin affects polymerization, depolymerization and neurotoxicity of Abeta peptide.
Morgan C; Bugueño MP; Garrido J; Inestrosa NC
Peptides; 2002 Jul; 23(7):1229-40. PubMed ID: 12128080
[TBL] [Abstract][Full Text] [Related]
7. Kisspeptin prevention of amyloid-β peptide neurotoxicity in vitro.
Milton NG; Chilumuri A; Rocha-Ferreira E; Nercessian AN; Ashioti M
ACS Chem Neurosci; 2012 Sep; 3(9):706-19. PubMed ID: 23019497
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity.
Doré S; Kar S; Quirion R
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4772-7. PubMed ID: 9114067
[TBL] [Abstract][Full Text] [Related]
9. Alpha 1-antichymotrypsin interaction with A beta (1-42) does not inhibit fibril formation but attenuates the peptide toxicity.
Aksenov MY; Aksenova MV; Carney JM; Butterfield DA
Neurosci Lett; 1996 Oct; 217(2-3):117-20. PubMed ID: 8916086
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation.
Hughes E; Burke RM; Doig AJ
J Biol Chem; 2000 Aug; 275(33):25109-15. PubMed ID: 10825171
[TBL] [Abstract][Full Text] [Related]
11. Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention.
Takadera T; Sakura N; Mohri T; Hashimoto T
Neurosci Lett; 1993 Oct; 161(1):41-4. PubMed ID: 7504801
[TBL] [Abstract][Full Text] [Related]
12. Binding of proteases to fibrillar amyloid-beta protein and its inhibition by Congo red.
Chander H; Chauhan A; Chauhan V
J Alzheimers Dis; 2007 Nov; 12(3):261-9. PubMed ID: 18057560
[TBL] [Abstract][Full Text] [Related]
13. Heparin-binding properties of the amyloidogenic peptides Abeta and amylin. Dependence on aggregation state and inhibition by Congo red.
Watson DJ; Lander AD; Selkoe DJ
J Biol Chem; 1997 Dec; 272(50):31617-24. PubMed ID: 9395501
[TBL] [Abstract][Full Text] [Related]
14. [Amyloidogenic peptides such as beta-amyloid, amylin and calcitonin strongly enhance the susceptibility of rat hippocampal neurons to excitatory amino acids in vivo].
Morimoto K; Nagata S; Kubo T; Oda T; Kaneko I
Nihon Yakurigaku Zasshi; 1998 Oct; 112 Suppl 1():83P-87P. PubMed ID: 10190140
[TBL] [Abstract][Full Text] [Related]
15. Nicotine attenuates beta-amyloid peptide-induced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures.
Liu Q; Zhao B
Br J Pharmacol; 2004 Feb; 141(4):746-54. PubMed ID: 14757701
[TBL] [Abstract][Full Text] [Related]
16. Amidation of beta-amyloid peptide strongly reduced the amyloidogenic activity without alteration of the neurotoxicity.
Forloni G; Lucca E; Angeretti N; Della Torre P; Salmona M
J Neurochem; 1997 Nov; 69(5):2048-54. PubMed ID: 9349550
[TBL] [Abstract][Full Text] [Related]
17. Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions.
Fraser PE; Nguyen JT; Chin DT; Kirschner DA
J Neurochem; 1992 Oct; 59(4):1531-40. PubMed ID: 1402902
[TBL] [Abstract][Full Text] [Related]
18. Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid.
Aitken JF; Loomes KM; Konarkowska B; Cooper GJ
Biochem J; 2003 Sep; 374(Pt 3):779-84. PubMed ID: 12812521
[TBL] [Abstract][Full Text] [Related]
19. Glycosaminoglycans and sulphated polyanions attenuate the neurotoxic effects of beta-amyloid.
Sadler II; Hawtin SR; Tailor V; Shearman MS; Pollack SJ
Biochem Soc Trans; 1995 Feb; 23(1):106S. PubMed ID: 7758665
[No Abstract] [Full Text] [Related]
20. BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells.
Oskarsson ME; Hermansson E; Wang Y; Welsh N; Presto J; Johansson J; Westermark GT
Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2752-E2761. PubMed ID: 29507232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
